Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Photodiagnosis Photodyn Ther ; 15: 236-44, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27288253

RESUMEN

BACKGROUND: Photodynamic Therapy (PDT) using Aminolevulinic acid (ALA) and derivative molecules as topical medication and as a precursor of protoporphyrin (PPIX), is limited due to low permeation through skin or efficiency in porphyrin production. This behavior affects the production and homogeneity of PPIX distribution on superficial skin and in the deeper skin layers. Many authors propose alternatives to solve this such as, modification in the ALA and derivativemolecules, modifying the chemical properties of emulsion external phase or incorporating a delivery system to the emulsion. The goal of this study is to discuss what proportion of ALA and Methyl aminolevulinate (MAL) on mixtures increase the amount and uniformity of PPIX formation at superficial skin by fluorescence evaluations. METHODS: The study was conducted in vivo using a pig skin model. PPIX production was monitored using fluorescence spectroscopy and widefield fluorescence imaging on skin surface. 20% of ALA and MAL cream were done mixing the following proportions: ALA, M2 (80% ALA-20% MAL), M3 (60% ALA-40% MAL), M4 (50% ALA-MAL), M5 (40% ALA-60% MAL), M6 (20% ALA-80% MAL) and MAL. RESULTS: Mixtures M3, M4, and M5 showed the most PPIX production on skin by widefield fluorescence imaging and fluorescence spectroscopy in 3h of incubation. These results suggest that 50% of ALA and MAL in the same mixture increase the PPIX production in amount, homogeneity and time production when compared to ALA and MAL. This has a positive impact on photodynamic damage optimizing the PDT treatment.


Asunto(s)
Ácidos Levulínicos/farmacocinética , Microscopía Fluorescente/métodos , Protoporfirinas/metabolismo , Absorción Cutánea/fisiología , Piel/efectos de los fármacos , Piel/metabolismo , Administración Cutánea , Animales , Colorantes Fluorescentes/administración & dosificación , Colorantes Fluorescentes/farmacocinética , Humanos , Ácidos Levulínicos/administración & dosificación , Masculino , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/administración & dosificación , Fármacos Fotosensibilizantes/farmacocinética , Absorción Cutánea/efectos de los fármacos , Porcinos , Ácido Aminolevulínico
2.
J Biophotonics ; 8(9): 723-9, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25319567

RESUMEN

Photodynamic therapy (PDT) is used for skin treatments of premalignant and cancer lesions and recognized as a non-invasive technique that combines tissue photosensitization and subsequent exposure to light to induce cell death. However, it is limited to the treatment of superficial lesions, mainly due to the low cream penetration. Therefore, the improvement of transdermal distribution of aminolevulinic acid (ALA) is needed. In this study, the kinetics and homogeneity of production of ALA-induced PpIX after the skin pre-treatment with microneedles rollers of 0.5, 1.0 and 1.5 mm length were investigated. An improvement in homogeneity and production of PpIX was shown in a porcine model. Widefield fluorescence imaging three hours after the topical application of ALA-cream in the combined treatment with microeedles rollers.


Asunto(s)
Ácido Aminolevulínico/farmacología , Agujas , Protoporfirinas/metabolismo , Piel/efectos de los fármacos , Piel/metabolismo , Ácido Aminolevulínico/metabolismo , Animales , Cinética , Masculino , Profármacos/metabolismo , Profármacos/farmacología , Sus scrofa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA